Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
178 *
Mon, 8/1/2016,
10:30 AM -
12:20 PM
CC-W187a
Statistical Solutions to Problems in Specific Therapeutic Areas or Populations — Contributed Papers
Biopharmaceutical Section
Chair(s): Lynn Navale, Kite Pharma
10:35 AM
An Integrated Bayesian Posterior Probability with Simon Two-Stage Design for a Randomized Phase II Clinical Trial
—
Dung-Tsa Chen, Moffitt Cancer Center ; Po-Yu Huang, National Chung-Hsing University ; Hui-Yi Lin, Louisiana State University Health Sciences Center
10:50 AM
Correcting Treatment Effect for Treatment Switching in Randomized Oncology Trials with a Generalized Rank-Preserving Structural Failure Time Model
—
Jin Zhang, Merck ; Cong Chen, Merck
11:05 AM
Comparison of Treatment Effects Between U.S. and Non-U.S. Study Sites in Multiregional Alzheimer's Disease Clinical Trials
—
Jingyu Luan, FDA ; Hsien-Ming James Hung, FDA ; Ranjit Mani, FDA
11:20 AM
Two-Stage Statistical Evaluation of Cardiovascular Safety Assessment of Diabetes Drugs
—
Raymond Lam, Merck ; Shailaja Suryawanshi, Merck
11:35 AM
A Bayesian Approach for Classification Based on Continuous Glucose Monitoring Data of Diabetic Patients
—
Hui Zheng, Harvard Medical School
11:50 AM
Mixture Model for Radiographic Progression in Psoriatic Arthritis
—
Bin Dong, Janssen R&D ; Jiandong lu, Janssen R&D
12:05 PM
Efficacy Outcomes in Elderly Patients Treated with Pembrolizumab and Nivolumab
—
Huanyu Chen, FDA ; Harpreet Singh, FDA ; Sirisha Mushti, FDA ; Kun He, FDA ; Rajeshwari Sridhara, FDA
